US Government To Purchase $165 Million Worth of Anthrax Drugs
Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics on June 23, 2006
Under the Project BioShield Act of 2004, the US government has agreed to purchase 20,000 doses of ABthraxâ„¢, an experimental drug developed by Human Genome Sciences against inhalational anthrax disease.
"HGS has demonstrated the efficacy of ABthrax in multiple pre-clinical studies in relevant animal models, and its safety and tolerability in a Phase 1 clinical trial in healthy adults. With our proven ability to scale up production in our manufacturing facilities, we expect to deliver ABthrax to the Strategic National Stockpile in 2008. Today's announcement is an important milestone in Human Genome Sciences' progress toward commercialization, since fulfilling the terms of this award will result in our company's first product sales."
Because of anthrax's potential use as a bioweapon, various efforts are also underway to develop anthrax vaccines through molecular farming, as well as anthrax antibiotics. In contrast to vaccines and antibiotics however, its developers claim ABthrax, a human monoclonal antibody to Bacillus anthracis, is a superior option because it affords immediate protection without the risks of the emergence of resistant strains.
Read more from HGSI's press release and from the Washington Business Journal. A webcast discussing the US government's purchase of ABthrax is also available here for the next few days.
Tags: anthrax bioweapon
Vote for US Government To Purchase $165 Million Worth of Anthrax Drugs:
|
Rating: 9.00 out of 6 vote(s) cast.
|
Response from:
substance abuse
(05/10/07 9:46am)
It is a very sad image, a country buying antidotes for its people against some substace used to put away animals.That should give a pretty good image that the threating ones have of the american people, not considering them even human...
Response from:
printing brochures
(05/17/07 1:06am)
Anthrax is a deadly disease for humans and animals. I think the bacteria was genetically modified to achieve such a virulent reaction.
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
